JP Morgan Chase
ZYME icon

JP Morgan Chase’s Zymeworks ZYME Stock Holding History

JP Morgan Chase’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Buy
114,072
+79,064
+226% +$1.87M ﹤0.01% 3852
2025
Q4 		$922K Buy
35,008
+1,124
+3% +$24.5K ﹤0.01% 4662
2025
Q3 		$579K Sell
33,884
-407,806
-92% -$5.84M ﹤0.01% 4929
2025
Q2 		$5.54M Buy
441,690
+403,281
+1,050% +$4.8M ﹤0.01% 3058
2025
Q1 		$457K Sell
38,409
-73,574
-66% -$1M ﹤0.01% 4840
2024
Q4 		$1.64M Buy
111,983
+72,703
+185% +$1.02M ﹤0.01% 4296
2024
Q3 		$493K Sell
39,280
-193
-0.5% -$2.1K ﹤0.01% 4900
2024
Q2 		$336K Buy
39,473
+2,894
+8% +$25.8K ﹤0.01% 4893
2024
Q1 		$385K Sell
36,579
-13,105
-26% -$146K ﹤0.01% 4965
2023
Q4 		$516K Buy
49,684
+13,280
+36% +$106K ﹤0.01% 4775
2023
Q3 		$231K Sell
36,404
-5,163
-12% -$38.1K ﹤0.01% 4978
2023
Q2 		$359K Buy
41,567
+41,234
+12,383% +$369K ﹤0.01% 4696
2023
Q1 		$3K Buy
333
+322
+2,927% +$2.81K ﹤0.01% 6365
2022
Q4 		$0 Hold
11
– – ﹤0.01% 7064
2022
Q3 		$0 Hold
11
– – ﹤0.01% 6915
2022
Q2 		$0 Sell
11
-686,773
-100% -$4.15M ﹤0.01% 6948
2022
Q1 		$4.5M Buy
686,784
+610,892
+805% +$5.44M ﹤0.01% 3091
2021
Q4 		$1.25M Buy
75,892
+44,913
+145% +$936K ﹤0.01% 4228
2021
Q3 		$900K Buy
30,979
+30,844
+22,847% +$1.03M ﹤0.01% 4394
2021
Q2 		$5K Sell
135
-23,924
-99% -$759K ﹤0.01% 6134
2021
Q1 		$760K Sell
24,059
-8,249
-26% -$335K ﹤0.01% 4418
2020
Q4 		$1.53M Buy
+32,308
New +$1.5M ﹤0.01% 3680
2020
Q3 		– Sell
-5
Closed – – 5831
2020
Q2 		$0 Sell
5
-10,849
-100% -$400K ﹤0.01% 5748
2020
Q1 		$385K Buy
+10,854
New +$444K ﹤0.01% 3952
2019
Q3 		– Sell
-79,296
Closed -$1.75M – 5995
2019
Q2 		$1.75M Buy
79,296
+60,472
+321% +$1.11M ﹤0.01% 3480
2019
Q1 		$305K Buy
+18,824
New +$292K ﹤0.01% 4442

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase's ZYME Position: Q1 2026 in Review

JP Morgan Chase increased its Zymeworks (ZYME) stake by 226% in Q1 2026, buying an estimated $1.87M and bringing the position to 114,072 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

JP Morgan Chase first reported a position in ZYME in Q1 2019 and has held it in 26 quarters since. The position peaked at $5.54M in Q2 2025. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • JP Morgan Chase held 114,072 shares of Zymeworks worth $2.76M as of Q1 2026.
  • JP Morgan Chase bought 79,064 Zymeworks shares in Q1 2026, an estimated $1.87M.
  • Zymeworks made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3852 holding.
  • JP Morgan Chase first reported a position in Zymeworks in Q1 2019 and has held it in 26 quarters since.
  • JP Morgan Chase's Zymeworks position peaked at $5.54M in Q2 2025.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.